ANTERIS TECHNOLOGIES LTD - Announcements

Market Cap $413.0M Add to my watchlist

Healthcare Medical Devices

Anteris Technologies Ltd is an Australia-based company that is engaged in the research... Anteris Technologies Ltd is an Australia-based company that is engaged in the research and development (R&D) of its structural heart products. The Company is engaged in the manufacture and sale of ADAPT regenerative tissue products globally. It is focused on developing biomimetic transcatheter aortic valve replacement (TAVR) for the treatment of aortic stenosis. ADAPT is the Company’s patented anti-calcification tissue technology. Its DurAVR THV is a three dimensional (3D) single piece valve and is a biomimetic design that replicates the normal blood flow of a healthy human aortic valve. The Company also provides ComASUR Delivery System, a balloon expandable system with the ability to rotate valves for predictable alignment with the heart’s native commissure. More

Announcements

Filter Results

All Price Sensitive Only

AVR	Notification regarding unquoted securities - AVR		02/05/24	20.06KB	Share
AVR	Notice of Annual General Meeting/Proxy Form		29/04/24	801.48KB	Share
AVR	Cleansing Notice		18/04/24	226.23KB	Share
AVR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	18/04/24	362.14KB	Share
AVR	Application for quotation of securities - AVR		17/04/24	17.64KB	Share
AVR	Application for quotation of securities - AVR		15/04/24	17.61KB	Share
AVR	Corporate Governance Statement and Appendix 4G		15/04/24	771.58KB	Share
AVR	Annual Report to shareholders		15/04/24	6.52MB	Share
AVR	Application for quotation of securities - AVR		11/04/24	17.63KB	Share
AVR	Change in substantial holding		10/04/24	246.5KB	Share
AVR	Notice of AGM Date and Closing of Nominations for Directors		10/04/24	176.01KB	Share
AVR	Proposed issue of securities - AVR		10/04/24	15.46KB	Share
AVR	Capital Raise	PRICE SENSITIVE	10/04/24	138.25KB	Share
AVR	Trading Halt	PRICE SENSITIVE	09/04/24	286.67KB	Share
AVR	Pause in trading	PRICE SENSITIVE	09/04/24	116.02KB	Share
AVR	Change of Director's Interest Notice		02/04/24	241.09KB	Share
AVR	Cleansing Notice		27/03/24	194.92KB	Share
AVR	Notification regarding unquoted securities - AVR		26/03/24	17.98KB	Share
AVR	Application for quotation of securities - AVR		26/03/24	17.63KB	Share
AVR	Notification of cessation of securities - AVR		26/03/24	16.28KB	Share
AVR	Cleansing Notice		13/03/24	195.29KB	Share
AVR	Application for quotation of securities - AVR		12/03/24	17.64KB	Share
AVR	Updated 30-day DurAVR THV Clinical Data	PRICE SENSITIVE	12/03/24	195.95KB	Share
AVR	Cleansing Notice		11/03/24	195.1KB	Share
AVR	Application for quotation of securities - AVR		11/03/24	20.08KB	Share
AVR	Preliminary Final Report	PRICE SENSITIVE	28/02/24	1.29MB	Share
AVR	Notification of cessation of securities - AVR		22/02/24	14.27KB	Share
AVR	Notification regarding unquoted securities - AVR		22/02/24	17.98KB	Share
AVR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	352.81KB	Share
AVR	Application for quotation of securities - AVR		25/01/24	27.02KB	Share
AVR	Three ViV Patients Completed under Health Canada SAP		22/01/24	179.35KB	Share
AVR	Cleansing Notice		11/01/24	220.43KB	Share
AVR	Application for quotation of securities - AVR		11/01/24	26.93KB	Share
AVR	Notification of cessation of securities - AVR		11/01/24	23.6KB	Share
AVR	Investor Presentation	PRICE SENSITIVE	09/01/24	2.53MB	Share
AVR	Change in substantial holding		03/01/24	162.27KB	Share
AVR	Cleansing Notice		22/12/23	146.72KB	Share
AVR	Application for quotation of securities - AVR		21/12/23	26.93KB	Share
AVR	Update on Equity Raising	PRICE SENSITIVE	15/12/23	176.71KB	Share
AVR	Notification regarding unquoted securities - AVR		28/11/23	29.7KB	Share
AVR	Cleansing Notice		22/11/23	194.05KB	Share
AVR	Application for quotation of securities - AVR		21/11/23	27.17KB	Share
AVR	30-day Haemodynamic Results from the DurAVR US EFS Trial	PRICE SENSITIVE	21/11/23	231.09KB	Share
AVR	Change in substantial holding		07/11/23	1.95MB	Share
AVR	Change in substantial holding		03/11/23	165KB	Share
AVR	Cleansing Notice		03/11/23	219.97KB	Share
AVR	Application for quotation of securities - AVR		03/11/23	27.11KB	Share
AVR	Notification of cessation of securities - AVR		01/11/23	23.62KB	Share
AVR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/23	338.86KB	Share
AVR	Cleansing Notice		26/10/23	220.32KB	Share
AVR	Reinstatement to Official Quotation	PRICE SENSITIVE	26/10/23	86.42KB	Share
AVR	Proposed issue of securities - AVR		26/10/23	24.89KB	Share
AVR	Capital Raise	PRICE SENSITIVE	26/10/23	209.83KB	Share
AVR	Positive Results from Interim Analysis of DurAVR EFS Trial	PRICE SENSITIVE	25/10/23	239.22KB	Share
AVR	Suspension from Official Quotation	PRICE SENSITIVE	25/10/23	594.08KB	Share
AVR	Application for quotation of securities - AVR		24/10/23	26.93KB	Share
AVR	Trading Halt	PRICE SENSITIVE	23/10/23	613.94KB	Share
AVR	Anteris Completes DurAVR THV EFS Enrolment	PRICE SENSITIVE	17/10/23	232.36KB	Share
AVR	R&D Refund		13/10/23	224.67KB	Share
AVR	Notification of cessation of securities - AVR		06/10/23	23.11KB	Share
AVR	Cleansing Notice		29/09/23	220.39KB	Share
AVR	Application for quotation of securities - AVR		29/09/23	26.93KB	Share
AVR	Change of Director's Interest Notice x 4		20/09/23	296.46KB	Share
AVR	Notification regarding unquoted securities - AVR		19/09/23	30.53KB	Share
AVR	Anteris to Present at Cantor Healthcare Conference		12/09/23	206.94KB	Share
AVR	Results of Meeting		06/09/23	403.79KB	Share
AVR	Cleansing Notice		04/09/23	221.27KB	Share
AVR	Application for quotation of securities - AVR		01/09/23	26.95KB	Share
AVR	Appendix 4D and Half Year Financial Report Announcement	PRICE SENSITIVE	25/08/23	182.9KB	Share
AVR	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	25/08/23	714.97KB	Share
AVR	Cleansing Notice		18/08/23	159.93KB	Share
AVR	Application for quotation of securities - AVR		18/08/23	26.94KB	Share
AVR	Exceptional Results in Second Valve-in-Valve Case	PRICE SENSITIVE	14/08/23	145.89KB	Share
AVR	Notification of cessation of securities - AVR		09/08/23	23.05KB	Share
AVR	Notification regarding unquoted securities - AVR		09/08/23	29.62KB	Share
AVR	Commencement of American Depository Receipt Program	PRICE SENSITIVE	09/08/23	164.44KB	Share
AVR	Montefiore enrolls Patients in US Early Feasibility Study	PRICE SENSITIVE	09/08/23	208.28KB	Share
AVR	Notice of Extraordinary General Meeting/Proxy Form		07/08/23	703.33KB	Share
AVR	DurAVR first successful implantation Valve-in-Valve	PRICE SENSITIVE	31/07/23	155.23KB	Share
AVR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/23	305.43KB	Share
AVR	Notification of cessation of securities - AVR		20/07/23	23KB	Share
AVR	Cleansing Notice		13/07/23	161.22KB	Share
AVR	Application for quotation of securities - AVR		13/07/23	29.6KB	Share
AVR	Cleansing Notice		29/06/23	161.16KB	Share
AVR	Application for quotation of securities - AVR		29/06/23	26.94KB	Share
AVR	Cleansing Notice		22/06/23	160.58KB	Share
AVR	Application for quotation of securities - AVR		22/06/23	26.94KB	Share
AVR	Ceasing to be a substantial holder from MUFG		19/06/23	730.85KB	Share
AVR	Ceasing to be a substantial holder from MS		16/06/23	218.64KB	Share
AVR	Becoming a substantial holder from MUFG		16/06/23	567.72KB	Share
AVR	Becoming a substantial holder from MS		16/06/23	424.65KB	Share
AVR	Ceasing to be a substantial holder from MUFG		14/06/23	1.24MB	Share
AVR	Ceasing to be a substantial holder from MS		14/06/23	218.38KB	Share
AVR	Latest Patient Group Show Best Results to Date at 30 Days	PRICE SENSITIVE	13/06/23	177.4KB	Share
AVR	Becoming a substantial holder from MUFG		09/06/23	866.65KB	Share
AVR	DurAVR THV Demonstrate Sustained Haemodynamics to 1 Year	PRICE SENSITIVE	09/06/23	177.46KB	Share
AVR	Becoming a substantial holder from MS		09/06/23	434.33KB	Share
AVR	Ceasing to be a substantial holder from MUFG		07/06/23	808.41KB	Share
AVR	Ceasing to be a substantial holder from MS		07/06/23	278.1KB	Share
AVR	Becoming a substantial holder from MUFG		06/06/23	816.76KB	Share

AVR Notification regarding unquoted securities - AVR
02/05/24		20.06KB	Share
AVR Notice of Annual General Meeting/Proxy Form
29/04/24		801.48KB	Share
AVR Cleansing Notice
18/04/24		226.23KB	Share
AVR Quarterly Activities/Appendix 4C Cash Flow Report
18/04/24	PRICE SENSITIVE	362.14KB	Share
AVR Application for quotation of securities - AVR
17/04/24		17.64KB	Share
AVR Application for quotation of securities - AVR
15/04/24		17.61KB	Share
AVR Corporate Governance Statement and Appendix 4G
15/04/24		771.58KB	Share
AVR Annual Report to shareholders
15/04/24		6.52MB	Share
AVR Application for quotation of securities - AVR
11/04/24		17.63KB	Share
AVR Change in substantial holding
10/04/24		246.5KB	Share
AVR Notice of AGM Date and Closing of Nominations for Directors
10/04/24		176.01KB	Share
AVR Proposed issue of securities - AVR
10/04/24		15.46KB	Share
AVR Capital Raise
10/04/24	PRICE SENSITIVE	138.25KB	Share
AVR Trading Halt
09/04/24	PRICE SENSITIVE	286.67KB	Share
AVR Pause in trading
09/04/24	PRICE SENSITIVE	116.02KB	Share
AVR Change of Director's Interest Notice
02/04/24		241.09KB	Share
AVR Cleansing Notice
27/03/24		194.92KB	Share
AVR Notification regarding unquoted securities - AVR
26/03/24		17.98KB	Share
AVR Application for quotation of securities - AVR
26/03/24		17.63KB	Share
AVR Notification of cessation of securities - AVR
26/03/24		16.28KB	Share
AVR Cleansing Notice
13/03/24		195.29KB	Share
AVR Application for quotation of securities - AVR
12/03/24		17.64KB	Share
AVR Updated 30-day DurAVR THV Clinical Data
12/03/24	PRICE SENSITIVE	195.95KB	Share
AVR Cleansing Notice
11/03/24		195.1KB	Share
AVR Application for quotation of securities - AVR
11/03/24		20.08KB	Share
AVR Preliminary Final Report
28/02/24	PRICE SENSITIVE	1.29MB	Share
AVR Notification of cessation of securities - AVR
22/02/24		14.27KB	Share
AVR Notification regarding unquoted securities - AVR
22/02/24		17.98KB	Share
AVR Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	352.81KB	Share
AVR Application for quotation of securities - AVR
25/01/24		27.02KB	Share
AVR Three ViV Patients Completed under Health Canada SAP
22/01/24		179.35KB	Share
AVR Cleansing Notice
11/01/24		220.43KB	Share
AVR Application for quotation of securities - AVR
11/01/24		26.93KB	Share
AVR Notification of cessation of securities - AVR
11/01/24		23.6KB	Share
AVR Investor Presentation
09/01/24	PRICE SENSITIVE	2.53MB	Share
AVR Change in substantial holding
03/01/24		162.27KB	Share
AVR Cleansing Notice
22/12/23		146.72KB	Share
AVR Application for quotation of securities - AVR
21/12/23		26.93KB	Share
AVR Update on Equity Raising
15/12/23	PRICE SENSITIVE	176.71KB	Share
AVR Notification regarding unquoted securities - AVR
28/11/23		29.7KB	Share
AVR Cleansing Notice
22/11/23		194.05KB	Share
AVR Application for quotation of securities - AVR
21/11/23		27.17KB	Share
AVR 30-day Haemodynamic Results from the DurAVR US EFS Trial
21/11/23	PRICE SENSITIVE	231.09KB	Share
AVR Change in substantial holding
07/11/23		1.95MB	Share
AVR Change in substantial holding
03/11/23		165KB	Share
AVR Cleansing Notice
03/11/23		219.97KB	Share
AVR Application for quotation of securities - AVR
03/11/23		27.11KB	Share
AVR Notification of cessation of securities - AVR
01/11/23		23.62KB	Share
AVR Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23	PRICE SENSITIVE	338.86KB	Share
AVR Cleansing Notice
26/10/23		220.32KB	Share
AVR Reinstatement to Official Quotation
26/10/23	PRICE SENSITIVE	86.42KB	Share
AVR Proposed issue of securities - AVR
26/10/23		24.89KB	Share
AVR Capital Raise
26/10/23	PRICE SENSITIVE	209.83KB	Share
AVR Positive Results from Interim Analysis of DurAVR EFS Trial
25/10/23	PRICE SENSITIVE	239.22KB	Share
AVR Suspension from Official Quotation
25/10/23	PRICE SENSITIVE	594.08KB	Share
AVR Application for quotation of securities - AVR
24/10/23		26.93KB	Share
AVR Trading Halt
23/10/23	PRICE SENSITIVE	613.94KB	Share
AVR Anteris Completes DurAVR THV EFS Enrolment
17/10/23	PRICE SENSITIVE	232.36KB	Share
AVR R&D Refund
13/10/23		224.67KB	Share
AVR Notification of cessation of securities - AVR
06/10/23		23.11KB	Share
AVR Cleansing Notice
29/09/23		220.39KB	Share
AVR Application for quotation of securities - AVR
29/09/23		26.93KB	Share
AVR Change of Director's Interest Notice x 4
20/09/23		296.46KB	Share
AVR Notification regarding unquoted securities - AVR
19/09/23		30.53KB	Share
AVR Anteris to Present at Cantor Healthcare Conference
12/09/23		206.94KB	Share
AVR Results of Meeting
06/09/23		403.79KB	Share
AVR Cleansing Notice
04/09/23		221.27KB	Share
AVR Application for quotation of securities - AVR
01/09/23		26.95KB	Share
AVR Appendix 4D and Half Year Financial Report Announcement
25/08/23	PRICE SENSITIVE	182.9KB	Share
AVR Appendix 4D and Half Year Financial Report
25/08/23	PRICE SENSITIVE	714.97KB	Share
AVR Cleansing Notice
18/08/23		159.93KB	Share
AVR Application for quotation of securities - AVR
18/08/23		26.94KB	Share
AVR Exceptional Results in Second Valve-in-Valve Case
14/08/23	PRICE SENSITIVE	145.89KB	Share
AVR Notification of cessation of securities - AVR
09/08/23		23.05KB	Share
AVR Notification regarding unquoted securities - AVR
09/08/23		29.62KB	Share
AVR Commencement of American Depository Receipt Program
09/08/23	PRICE SENSITIVE	164.44KB	Share
AVR Montefiore enrolls Patients in US Early Feasibility Study
09/08/23	PRICE SENSITIVE	208.28KB	Share
AVR Notice of Extraordinary General Meeting/Proxy Form
07/08/23		703.33KB	Share
AVR DurAVR first successful implantation Valve-in-Valve
31/07/23	PRICE SENSITIVE	155.23KB	Share
AVR Quarterly Activities/Appendix 4C Cash Flow Report
28/07/23	PRICE SENSITIVE	305.43KB	Share
AVR Notification of cessation of securities - AVR
20/07/23		23KB	Share
AVR Cleansing Notice
13/07/23		161.22KB	Share
AVR Application for quotation of securities - AVR
13/07/23		29.6KB	Share
AVR Cleansing Notice
29/06/23		161.16KB	Share
AVR Application for quotation of securities - AVR
29/06/23		26.94KB	Share
AVR Cleansing Notice
22/06/23		160.58KB	Share
AVR Application for quotation of securities - AVR
22/06/23		26.94KB	Share
AVR Ceasing to be a substantial holder from MUFG
19/06/23		730.85KB	Share
AVR Ceasing to be a substantial holder from MS
16/06/23		218.64KB	Share
AVR Becoming a substantial holder from MUFG
16/06/23		567.72KB	Share
AVR Becoming a substantial holder from MS
16/06/23		424.65KB	Share
AVR Ceasing to be a substantial holder from MUFG
14/06/23		1.24MB	Share
AVR Ceasing to be a substantial holder from MS
14/06/23		218.38KB	Share
AVR Latest Patient Group Show Best Results to Date at 30 Days
13/06/23	PRICE SENSITIVE	177.4KB	Share
AVR Becoming a substantial holder from MUFG
09/06/23		866.65KB	Share
AVR DurAVR THV Demonstrate Sustained Haemodynamics to 1 Year
09/06/23	PRICE SENSITIVE	177.46KB	Share
AVR Becoming a substantial holder from MS
09/06/23		434.33KB	Share
AVR Ceasing to be a substantial holder from MUFG
07/06/23		808.41KB	Share
AVR Ceasing to be a substantial holder from MS
07/06/23		278.1KB	Share
AVR Becoming a substantial holder from MUFG
06/06/23		816.76KB	Share

REFRESH

1 2 3 4 5 6

(20min delay)
Last $21.50		Change 0.210(0.99%)		Mkt cap ! $413.0M

Open	High	Low	Value	Volume
$21.50	$21.50	$21.00	$247.6K	11.68K

Buyers (Bids)

No.	Vol.	Price($)
1	100	$21.20

Sellers (Offers)

Price($)	Vol.	No.
$21.50	244	1

View Market Depth

No.	Vol.	Price($)
1	100	21.200
1	412	21.150
1	493	21.100
1	949	21.000
1	500	20.800

Price($)	Vol.	No.
21.500	244	1
21.600	300	1
21.700	421	1
22.200	107	1
22.610	254	1

Last trade - 16.10pm 06/05/2024 (20 minute delay)


Last $21.21		Change 0.210 ( 0.09 %)
Open	High	Low	Volume
$21.19	$21.21	$21.19	143
Last updated 14.24pm 06/05/2024 ?

AVR (ASX) Chart

ANTERIS TECHNOLOGIES LTD - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories